AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Upstream Bio, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG017Y2X950
2.74▼ 0.25 (-8.36%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
2.99
Day's Range
2.70 – 2.96
52-Week Range
2.70 – 33.69
Volume
1.1M
Avg Volume
1.0M
Share Statistics
Shares Outstanding
Employees
75
Exchange
XNAS
Listed
2024-10-11
Share count as of August 4, 2026

Upstream Bio, Inc. Common Stock (UPB) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Upstream Bio, Inc. Common Stock (UPB)
What is Upstream Bio, Inc. Common Stock's Market Cap?
Upstream Bio, Inc. Common Stock's Market Cap is $150.1M, based on as-reported figures from SEC (XBRL) filings.
What is Upstream Bio, Inc. Common Stock's Enterprise Value?
Upstream Bio, Inc. Common Stock's Enterprise Value is -$111.0M, based on as-reported figures from SEC (XBRL) filings.
What is Upstream Bio, Inc. Common Stock's Price / Sales?
Upstream Bio, Inc. Common Stock's Price / Sales is 47.5×, based on as-reported figures from SEC (XBRL) filings.
What is Upstream Bio, Inc. Common Stock's EV / Revenue?
Upstream Bio, Inc. Common Stock's EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Upstream Bio, Inc. Common Stock's EV / EBITDA?
Upstream Bio, Inc. Common Stock's EV / EBITDA is 0.7×, based on as-reported figures from SEC (XBRL) filings.
What is Upstream Bio, Inc. Common Stock's Revenue (TTM)?
Upstream Bio, Inc. Common Stock's Revenue (TTM) is $3.2M, based on as-reported figures from SEC (XBRL) filings.
What is Upstream Bio, Inc. Common Stock's Net Income (TTM)?
Upstream Bio, Inc. Common Stock's Net Income (TTM) is -$156.5M, based on as-reported figures from SEC (XBRL) filings.
What is Upstream Bio, Inc. Common Stock's EBITDA?
Upstream Bio, Inc. Common Stock's EBITDA is -$169.8M, based on as-reported figures from SEC (XBRL) filings.
What is Upstream Bio, Inc. Common Stock's Diluted EPS (TTM)?
Upstream Bio, Inc. Common Stock's Diluted EPS (TTM) is -2.86, based on as-reported figures from SEC (XBRL) filings.
What is Upstream Bio, Inc. Common Stock's EBITDA Margin?
Upstream Bio, Inc. Common Stock's EBITDA Margin is -5376.3%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · UPBAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
Collaboration revenue
YoY growth-17.5%+82.7%+9.0%+12.5%
Operating expenses:
Research and development
General and administrative
Total operating expenses
% of revenue5581.0%4318.1%7011.2%5639.4%
Loss from operations
% of revenue-5481.0%-4218.1%-6911.2%-5539.4%
Other income (expense):
Interest income
Other income (expense), net
Total other income, net
Net loss
% of revenue-5136.1%-3925.6%-6356.1%-4941.1%
Net loss per share attributable to common stockholders, basic
Net loss per share attributable to common stockholders, diluted